A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA) (Q33349721)

26 July 2017

title

A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA) (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

12 December 2022

vaccinia virus

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1860736

12 December 2022

genetic recombination

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1860736

12 December 2022

viral genes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1860736

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

12 December 2022

H. Kaufman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1860736

12 December 2022

J. Schlom

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1860736

12 December 2022

J. Kantor

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1860736

12 December 2022

language of work or name

English

0 references

publication date

1 July 1991

1 reference

26 July 2017

30 July 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1860736

full work available at URL

12 December 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910480618

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910480618

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

International Journal of Cancer

12 December 2022

published in

1 reference

26 July 2017

1 reference

26 July 2017

1 reference

26 July 2017

page(s)

900-907

1 reference

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910480618

Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910480618

Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Active gamma-carboxylated human factor IX expressed using recombinant DNA techniques

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Use of vaccinia virus vectors to study protein processing in human disease. Normal nerve growth factor processing and secretion in cultured fibroblasts from patients with familial dysautonomia

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Cellular Immunity Against Tumor Antigens

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Active immunotherapy in colorectal cancer

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Serologic mapping and biochemical characterization of the carcinoembryonic antigen epitopes using fourteen distinct monoclonal antibodies

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Tumour prevention and rejection with recombinant vaccinia.

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Vaccinia virus: a selectable eukaryotic cloning and expression vector

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Structure of vaccinia DNA: analysis of the viral genome by restriction endonucleases

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Active-specific immunotherapy for melanoma

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Active specific immunotherapy in malignant melanoma

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Vaccinia virus expression vectors

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

12 December 2022

5769

Muraro

1985

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Immunohistochemistry of Carcino-Embryonic Antigen in the Embryo, Fetus and Adult

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Expression and cell type--specific processing of human preproenkephalin with a vaccinia recombinant

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

The carcinoembryonic antigen gene family: structure, expression and evolution.

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

12 December 2022

5674

Tran

1988

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

Expression of herpes simplex virus glycoprotein D on antigen presenting cells infected with vaccinia recombinants and protective immunity

12 December 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910480618

12 December 2022

Identifiers

1 reference

26 July 2017

1 reference